Life Sciences and Healthcare Leader ConcertAI Raises $150 Million Series C from Sixth Street at $1.9 Billion Valuation
ConcertAI SaaS and data solutions have rapidly emerged as the industry standard for accelerating clinical trials and patient outcomes CAMBRIDGE, Mass., March 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI), the leader in enterprise AI and real-world data (RWD) solutions for life sciences and healthcare, announced the close of its $150 million Series C investment from…